BLI - Berkeley Lights Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 CCL (-4.79%) CUK (-5.33%) CZR (2.75%) KSS (1.43%) MIDD (2.62%) AAL (-3.72%) MRO (5.02%) PWR (1.58%) WKHS (-5.05%) AMZN (0.77%) EWBC (3.02%) FTI (6.56%) H (1.67%) LB (2.96%) LUV (1.5%) MGM (-0.41%) MSTR (-3.94%) PBCT (2.8%) PK (-0.67%) PLTR (-3.16%) RCL (-5.57%) CX (1.19%) ETSY (1.12%) ETHUSD (%) DQ (-7.16%)

Down 10% to $47.28 today | Hit 52 week low at $47.28

BLI - Berkeley Lights Inc

$49.75 -3.98[-7.4%]

15 mins delayed data

People also watch :

+Watchlist

Analyst Ratings | Earnings

Previous Close	$53.72	Open	$54.00
Volume	3.06M	Market Cap
Yield		Last Dividend

Day

52 Week

Insider Selling: Berkeley Lights, Inc. (...	03/04/21
Berkeley Lights, Inc. (NASDAQ:BLI) CEO Eric Hobbs sold 203,967 shares of Berkeley Lights stock in a transaction on Monday, March 1st. The stock was so...

Insider Selling: Berkeley Lights, Inc. (...	03/04/21
Berkeley Lights, Inc. (NASDAQ:BLI) Director Michael E. Marks sold 20,000 shares of Berkeley Lights stock in a transaction that occurred on Monday, Mar...

Berkeley Lights to Participate in the 39...	01/04/21
EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the compa...

10 Of 2020's Top Performing IPOs	12/26/20
The year 2020 has brought new investors to the stock market and also seen the most companies go public since 2014. Here is a look at 10 of the top per...

Berkeley Lights Announces Pricing of Pub...	11/18/20
EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) ??? Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its pre...

Berkeley Lights Factors Likely to Have I...	11/12/20
Berkeley Lights announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by???

Repare Therapeutics (NYSE:BLI) Upgraded ...	10/23/20
Zacks Investment Research upgraded shares of Repare Therapeutics (NYSE:BLI) from a hold rating to a buy rating in a research report sent to investors ...

Repare Therapeutics (NYSE:BLI) Upgraded ...	10/20/20
Zacks Investment Research upgraded shares of Repare Therapeutics (NYSE:BLI) from a hold rating to a buy rating in a report released on Tuesday, Zacks....

Aldevron the First to Rapidly Discover H...	08/31/20
FARGO, N.D.--(BUSINESS WIRE)-- #Aldevron--Aldevron, a leading provider of antibody discovery and production services, today announced the successful d...

Health care CEO does 180 Zoom calls in t...	08/12/20
Being in charge of a health care company during a pandemic is a ton of work ??? just ask Eric Hobbs, CEO of Berkeley Lights, who met with 180 investor...

Berkeley Lights closes $205M IPO (NASDAQ...	07/21/20
Berkeley Lights (NASDAQ:BLI) has closed its IPO of ~9.3M common shares at $22 per share, including the full exercise of underwriters' over-allotment. ...

Berkeley Lights Announces Closing of Ini...	07/21/20
EMERYVILLE, Calif., July 21, 2020 -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the closing of its initial public offeri...

Berkeley Lights Announces Closing of Ini...	07/21/20
EMERYVILLE, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closi...

ANALYST RATINGS

4 analyst ratings (Last 3 months)

75.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	01/27/21
Stifel initiates coverage with Buy rating and announces Price Target of $105.00

EARNINGS

Date	2021-02-25 (BMO)	Est. (EPS/Rev.)	($0.20)/ 19.04M
Actual (EPS/Rev.)	$-0.19/ $21.75 M	EPS (TTM)	0

TRADERS TRACKING $BLI

No traders tracking are currently recommending this stock

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.